Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mohamed W Attwa, Adnan A Kadi & Hany W Darwish. (2020) Metabolic Stability Assessment of Larotrectinib Using Liquid Chromatography Tandem Mass Spectrometry. Drug Design, Development and Therapy 14, pages 111-119.
Read now
Read now
Articles from other publishers (23)
Qian Zhong, Xina Xiao, Yijie Qiu, Zhiqiang Xu, Chunyu Chen, Baochen Chong, Xinjun Zhao, Shan Hai, Shuangqing Li, Zhenmei An & Lunzhi Dai. (2023) Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm 4:3.
Crossref
Crossref
Aubrey Swilling, Robin Pham, Jason Wang, Kelly Vallance, Tyler Hamby & Anish Ray. (2023) Lessons Learned: Utilization of a Reference Laboratory for Targeted Sequencing of Pediatric Tumors at a Single Institution. Journal of Pediatric Hematology/Oncology 45:2, pages 63-69.
Crossref
Crossref
Jinying Gu, Qiuyu Wu, Qiuyue Zhang, Qidong You & Lei Wang. (2022) A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives. European Journal of Medicinal Chemistry 243, pages 114742.
Crossref
Crossref
Zhijie Wang, Jiwei Ren, Kun Jia, Yuming Zhao, Li Liang, Zitian Cheng, Fei Huang, Xiaofei Zhao, Jie Cheng, Shiyu Song, Tiancheng Sheng, Weiqi Wan, Qingqing Shu, Donglin Wu, Junhao Zhang, Tao Lu, Yadong Chen, Ting Ran & Shuai Lu. (2022) Identification and structural analysis of a selective tropomyosin receptor kinase C (TRKC) inhibitor. European Journal of Medicinal Chemistry 241, pages 114601.
Crossref
Crossref
Alanna J. Church, Laura B. Corson, Pei-Chi Kao, Alma Imamovic-Tuco, Deirdre Reidy, Duong Doan, Wenjun Kang, Navin Pinto, Luke Maese, Theodore W. Laetsch, AeRang Kim, Susan I. Colace, Margaret E. Macy, Mark A. Applebaum, Rochelle Bagatell, Amit J. Sabnis, Daniel A. Weiser, Julia L. Glade-Bender, Alan C. Homans, John Hipps, Haley Harris, Danielle Manning, Alyaa Al-Ibraheemi, Yvonne Li, Hersh Gupta, Andrew D. Cherniack, Ying-Chun Lo, Gianna R. Strand, Lobin A. Lee, R. Seth Pinches, Lorena Lazo De La Vega, Maegan V. Harden, Niall J. Lennon, Seong Choi, Hannah Comeau, Marian H. Harris, Suzanne J. Forrest, Catherine M. Clinton, Brian D. Crompton, Junne Kamihara, Laura E. MacConaill, Samuel L. Volchenboum, Neal I. Lindeman, Eliezer Van Allen, Steven G. DuBois, Wendy B. London & Katherine A. Janeway. (2022) Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nature Medicine 28:8, pages 1581-1589.
Crossref
Crossref
Troy Hutchens & Mena Mansour. (2022) Genetics in the endocrine system: the impact of the TRK family. Diagnostic Histopathology 28:7, pages 313-320.
Crossref
Crossref
Hui Wang, Zhi‐Wei Li, Qiuxiang Ou, Xue Wu, Misako Nagasaka, Yang Shao, Sai‐Hong Ignatius Ou & Yu Yang. (2022)
NTRK
fusion positive colorectal cancer is a unique subset of
CRC
with high
TMB
and microsatellite instability
. Cancer Medicine 11:13, pages 2541-2549.
Crossref
Crossref
Aleksandra Sochacka-Ćwikła, Marcin Mączyński & Andrzej Regiec. (2022) FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021. Molecules 27:7, pages 2259.
Crossref
Crossref
Cecilia C. Ayala-Aguilera, Teresa Valero, Álvaro Lorente-Macías, Daniel J. Baillache, Stephen Croke & Asier Unciti-Broceta. (2021) Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis. Journal of Medicinal Chemistry 65:2, pages 1047-1131.
Crossref
Crossref
Michele Araújo Pereira, Feliciana Lage de Oliveira Marinho, Laura Rabelo Leite, Luige Biciati Alvim, Frederico Scott Varella Malta, Fabiana Kalina Marques & Aline Brito de Lima. 2022. Breast Cancer: From Bench to Personalized Medicine. Breast Cancer: From Bench to Personalized Medicine
477
518
.
Yu-Wei Cheng, Anders Meyer, Maureen A Jakubowski, Sean O Keenan, Jay E Brock, Elizabeth M Azzato, Michael Weindel, Daniel H Farkas & Brian P Rubin. (2021) Gene Fusion Identification Using Anchor-Based Multiplex PCR and Next-Generation Sequencing. The Journal of Applied Laboratory Medicine 6:4, pages 917-930.
Crossref
Crossref
Ross Mangum, Jacquelyn Reuther, Kelsey C. Bertrand, Raghu Chandramohan, Marcia K. Kukreja, Arnold C. Paulino, Donna Muzny, Jianhong Hu, Richard A. Gibbs, Daniel J. Curry, Fatema Malbari, Murali M. Chintagumpala, Adekunle M. Adesina, Kevin E. Fisher, Stephen C. Mack, Sharon E. Plon, Angshumoy Roy, D. Williams Parsons & Frank Y. Lin. (2021)
Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an
NTRK2
Fusion: The Impact of Integrated Genomic Profiling
. JCO Precision Oncology:5, pages 1221-1227.
Crossref
Crossref
Angelina T. Regua, Noah R. Aguayo, Sara Abu Jalboush, Daniel L. Doheny, Sara G. Manore, Dongqin Zhu, Grace L. Wong, Austin Arrigo, Calvin J. Wagner, Yang Yu, Alexandra Thomas, Michael D. Chan, Jimmy Ruiz, Guangxu Jin, Roy Strowd, Peiqing Sun, Jiayuh Lin & Hui-Wen Lo. (2021) TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers 13:10, pages 2340.
Crossref
Crossref
James E. Frampton. (2021) Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC. Drugs 81:6, pages 697-708.
Crossref
Crossref
Fiorella Guadagni, Sofia Cutaia, Giorgio Madonia, Valerio Gristina, Lorena Incorvaia, Lidia Rita Corsini, Daniele Fanale, Claudio Longhitano, Federica Martorana, Juan Lucio Iovanna, Viviana Bazan & Paolo Vigneri. 2021. Practical Medical Oncology Textbook. Practical Medical Oncology Textbook
43
64
.
Li Li, Ling Lin, Jamunarani Veeraraghavan, Yiheng Hu, Xian Wang, Sanghoon Lee, Ying Tan, Rachel Schiff & Xiao-Song Wang. (2020) Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance. Breast Cancer Research 22:1.
Crossref
Crossref
Yuekun Wang, Piaopiao Long, Yu Wang & Wenbin Ma. (2020) NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma. Frontiers in Oncology 10.
Crossref
Crossref
T. Yoshino, G. Pentheroudakis, S. Mishima, M.J. Overman, K.-H. Yeh, E. Baba, Y. Naito, F. Calvo, A. Saxena, L.-T. Chen, M. Takeda, A. Cervantes, H. Taniguchi, K. Yoshida, Y. Kodera, Y. Kitagawa, J. Tabernero, H. Burris & J.-Y. Douillard. (2020) JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions. Annals of Oncology 31:7, pages 861-872.
Crossref
Crossref
Eleonora Lai, Nicole Liscia, Clelia Donisi, Stefano Mariani, Simona Tolu, Andrea Pretta, Mara Persano, Giovanna Pinna, Francesca Balconi, Annagrazia Pireddu, Valentino Impera, Marco Dubois, Marco Migliari, Dario Spanu, Giorgio Saba, Silvia Camera, Francesca Musio, Pina Ziranu, Marco Puzzoni, Laura Demurtas, Valeria Pusceddu, Manuela Dettori, Elena Massa, Francesco Atzori, Mariele Dessì, Giorgio Astara, Clelia Madeddu & Mario Scartozzi. (2020) Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer. Cancers 12:5, pages 1214.
Crossref
Crossref
Christopher D. Steele & Nischalan Pillay. (2020) The genomics of undifferentiated sarcoma of soft tissue: Progress, challenges and opportunities. Seminars in Cancer Biology 61, pages 42-55.
Crossref
Crossref
Christian Rolfo. (2020) NTRK gene fusions: a rough diamond ready to sparkle. The Lancet Oncology 21:4, pages 472-474.
Crossref
Crossref
Paula Chu, Sarah Batson, Matthew Hodgson, Catherine R Mitchell & Anna Steenrod. (2020) Systematic review of neurotrophic tropomyosin-related kinase inhibition as a tumor-agnostic management strategy. Future Oncology 16:4, pages 61-74.
Crossref
Crossref
Tarek Assi, Elie Rassy, Hussein Nassereddine, Fadi Farhat, Fadi El Karak, Joseph Kattan & Marwan Ghosn. (2020) TRK inhibition in soft tissue sarcomas: A comprehensive review. Seminars in Oncology 47:1, pages 73-84.
Crossref
Crossref